Featured Image
Perspectives
Read the Original
This page is a summary of: Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine, OncoTargets and Therapy, January 2016, Dove Medical Press,
DOI: 10.2147/ott.s92182.
You can read the full text:
Contributors
The following have contributed to this page